반응식
[CH2:1]([O:5][C:6]([N:8](C)[C:9]1([C:21](O)=[O:22])[CH2:18][CH2:17][C:16]2[C:11](=[C:12]([O:19][CH3:20])[CH:13]=[CH:14][CH:15]=2)[CH2:10]1)=[O:7])[CH:2]([CH3:4])[CH3:3].S(O)(O)(=O)=O.[CH2:30]([N:32]([CH2:40][CH3:41])[C:33]1[CH:38]=[CH:37][C:36]([NH2:39])=[CH:35][CH:34]=1)[CH3:31].[CH3:42]CN(CC)CC.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F>CN(C=O)C>[CH2:40]([N:32]([CH2:30][CH3:31])[C:33]1[CH:38]=[CH:37][C:36]([NH:39][C:21]([C:9]2([NH:8][C:6](=[O:7])[O:5][CH2:1][CH:2]([CH3:4])[CH3:3])[CH2:18][CH2:17][C:16]3[C:11](=[C:12]([O:19][CH3:20])[CH:13]=[CH:14][CH:15]=3)[CH2:10]2)=[O:22])=[C:35]([CH3:42])[CH:34]=1)[CH3:41]참가 물질
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
The acid from Example 33F was dissolved in DMF (6.0 mL). N,N-diethyl-benzene-1,4-diamine sulfate (786 mg, 3.0 mmol), Et3N (1.0 g, 10 mmol), and TBTU (963 mg, 3.0 mmol) were added and the resulting mixture was stirred overnight and purified by column chromatography to provide the titled compound (680 mg, 40% over two steps). 1H NMR (400 MHz, DMSO-D6) δ 9.07 (s, 1H), 7.30 (d, J=8.4 Hz, 2H), 7.07 (t, J=7.6 Hz, 1H), 6.77 (d, J=8.0 Hz, 1H), 6.68 (d, J=7.2 Hz, 1H), 6.60 (d, J=8.8 Hz, 2H), 3.78 (s, 3H), 3.76 (m, 2H), 3.27 (q, J=6.8 Hz, 4H), 3.12 (d, J=17.6 Hz, 1H), 2.87 (d, J=16.0 Hz, 1H), 2.85 (s, 3H), 2.64 (m, 2H), 2.32 (m, 1H), 2.19 (m, 1H), 1.80 (m, 1H), 1.05 (t, J=6.8 Hz, 6H), and 0.85 (d, J=6.4 Hz, 6H). MS (ESI) positive ion 482 (M+H)+.
후처리
- custompurified by column chromatography
출처 및 근거
- ORD 기록
- ord-e2d3c8b9fd874656aadaad42d3aa7149
- 출처 데이터셋
- uspto-grants-2006_10
- 특허 번호
- US07115767B2
연결된 노트
불러오는 중…